Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $66.29, but opened at $71.00. Eurofins Scient shares last traded at $71.00, with a volume of 100 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.
Get Our Latest Report on Eurofins Scient
Eurofins Scient Stock Performance
About Eurofins Scient
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Read More
- Five stocks we like better than Eurofins Scient
- The $132 Billion Infrastructure Pivot You Might Have Missed
- Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings
- Rewiring AI: NextEra Energy Sparks a Mega Merger
- Flipping the Switch: Is Ford the Next Big Energy Stock?
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
